Abogen has been invited to VIF World 2026 in Shanghai, March 11-14. 

Dr. Bo Ying, CEO of Abogen, will join global industry giants, academic pioneers, and public health leaders to explore the structured synergy between vaccine science, industrial manufacturing, and global health policy. He will chair the "RNA Technologies" morning session and present strategic insights into mRNA-based strategies and collaboration. 

Abogen's Speaking Sessions:

1、Plenary Session
Topic: The mRNA Playbook: Engineering a Global Biopharma Platform
Date & Time: 9:25 AM, March 12, 2026

2、WHO & MPP Side Event: mRNA Technology Transfer Programme

Topic: Reflections on Partnering with MPP and the Value of Structured Collaboration
Date & Time: 5:55 - 6:15 PM, March 12, 2026